Death Benefit

(4)
Death Benefit image
ISBN-10:

0230754937

ISBN-13:

9780230754935

Author(s): ROBIN COOK
Edition: Open market ed
Released: Jan 01, 2011
Format: Paperback, 464 pages

Description:

This is the next book from the master of the medical thriller. Pia Grazdani is an exceptional yet aloof medical student working closely with Columbia University Medical Center's premier scientist. Their cutting edge research could revolutionize health care; creating replacement organs. Thorough her work with the brilliant molecular geneticist Dr Tobias Rothman, Pia knows she will not only be given the chance to fulfil her professional ambitions - but also maybe finally push aside all memories of her difficult, abusive childhood. However, tragedy strikes in the lab. Pia, with the help of infatuated classmate George Wilson, launches an investigation into the unforeseen calamity in the hospital's supposedly secure biosafety lab. Meanwhile, two ex-Wall Street whiz-kids think they have found another lodestone in the nation's multi-trillion dollar life insurance industry, and race to find ways to control the data - and make a killing. And as Pia and George dig deeper into the events at the lab, matters become increasingly suspicious...

Best prices to buy, sell, or rent ISBN 9780230754935




Related Books

Frequently Asked Questions about Death Benefit

You can buy the Death Benefit book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $15.66 on Amazon and is available from 2 sellers at the moment.

If you’re interested in selling back the Death Benefit book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Death Benefit book, the best buyback offer comes from and is $ for the book in good condition.

Not enough insights yet.

Not enough insights yet.